Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
CRYSTALLINE LEVOPRAZIQUANTEL, AND PREPARATION METHOD AND APPLICATION THEREOF
Document Type and Number:
WIPO Patent Application WO/2015/055126
Kind Code:
A1
Abstract:
The present invention relates to crystalline levopraziquantel, and preparation method and application thereof. The X-ray diffraction pattern (CuKα radiation) of crystalline levopraziquantel at 25oC shows the following diffraction peaks: 2-Theta=6.9±0.2°, 8.3±0.2°, 15.1±0.2°, 17.4±0.2°, 19.8±0.2°, 21.9±0.2°, 24.3±0.2°, or d=12.74±0.20Å, 10.61±0.20Å, 5.87±0.20Å, 5.09±0.20Å, 4.48±0.20Å, 4.06±0.20Å, and 3.66±0.20Å. Compared with an existing crystalline praziquantel, the crystal form of the present invention has features of better solubility, drug effect, and pharmacokinetics. The preparation method of the present invention has good repeatability, and is environmentally friendly and of low cost, and is able to operate at a normal pressure and temperature, thus being suitable for large-scale production.

Inventors:
QIAN MINGXIN (CN)
HE RENYANG (CN)
QIAO CHUNSHENG (CN)
SHI JUNWEI (CN)
Application Number:
PCT/CN2014/088700
Publication Date:
April 23, 2015
Filing Date:
October 16, 2014
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
TONGLI BIOMEDICAL CO LTD (CN)
International Classes:
C07D471/04; A61K31/4985; A61P33/02; A61P33/06; A61P33/10; A61P33/12
Foreign References:
CN102911979A2013-02-06
CN103333931A2013-10-02
CN103160562A2013-06-19
Attorney, Agent or Firm:
SUZHOU CREATOR PATENT & TRADEMARK AGENCY LTD. (CN)
苏州创元专利商标事务所有限公司 (CN)
Download PDF: